· RAAS flowchart
· Hormone effects
· Drug effects
Summary |
· Whole body response to hypotension and hypovolaemia · Vasoconstriction -> ↑SVR / afterload · ↑Fluid and sodium retention -> ↑ECF volume -> ↑preload -> ↑CO · ↑Blood pressure |
AT2 |
· AGTR1 receptor agonist · Systemic vasoconstriction · Renal efferent > afferent arteriolar vasoconstriction · ↑Na+/H2O reabsorption from proximal tubule · ↑Release of aldosterone and ADH · ↑Thirst |
Aldosterone |
· Mineralocorticoid receptor agonist · ↑ENaC activity -> ↑ECF [Na+] (distal nephron, colon, sweat gland) · ↑Release of ADH release (indirect via ↑[Na+]) |
Bradykinin |
· Bradykinin receptor agonist · ↑Release of vasoactive factors (prostanoids, nitric oxide) · Vasodilation, capillary leak, diuresis |
MoA |
· ACEi: prevent formation of AT2 and breakdown of bradykinin · ARB: competitive antagonist at AGTR |
Therapeutic |
· ↓Preload, ↓afterload -> ↓LV wall stress -> ↓remodelling -> ↓progression of heart failure · ↓Risk of AMI · ↓Risk of diabetic nephropathy · ↓Blood pressure |
Adverse |
· Vasodilation + hypovolaemia -> peri-op refractory hypotension · ↓Aldosterone -> hyperkalaemia (important if renal impairment) · Renal vasoconstriction -> dysfunction (especially peri-op, thiazide, NSAID) · Bradykinin -> angioedema, cough (ACEi only) |
Feedback welcome at ketaminenightmares@gmail.com